Announcements
7 July 2026
Meet Us at the CED/NOF-IADR 2026 Oral Health Research Congress, 3–5 September 2026, Lisbon, Portugal
6 July 2026
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues in the “Gastroenterology & Hepatopancreatobiliary Medicine” Section
We are pleased to share several selected highly cited papers and hot topic Special Issues in the “Gastroenterology & Hepatopancreatobiliary Medicine” Section of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). The digestive system is a very attractive and useful organ system to explore and deepen our understanding in human science. This Section covers not only organic diseases such as inflammatory diseases, infectious diseases, intractable immunological diseases, and malignant tumors, but also functional diseases such as irritable bowel syndrome. Relevant subject areas include, but are not limited to, the following:
- Esophagus;
- Stomach;
- Duodenum;
- Small intestine;
- Liver;
- Biliary tract;
- Pancreas;
- Cancer;
- Functional GI disorders;
- Gut microbiota.
To browse newly published papers and other open Special Issues, please visit: https://www.mdpi.com/journal/jcm/sections/Gastroenterology_Hepatology.
1. “The Role of Therapeutic Endoscopic Ultrasound in Management of Malignant Double Obstruction (Biliary and Gastric Outlet): A Comprehensive Review with Clinical Scenarios”
by Giuseppe Dell’Anna Rubino Nunziata, Claudia Delogu, Petra Porta, Maria Vittoria Grassini, Jahnvi Dhar, Rukaia Barà, Sarah Bencardino, Jacopo Fanizza and Francesco Vito Mandarino
J. Clin. Med. 2024, 13(24), 7731; https://doi.org/10.3390/jcm13247731
Full text available online: https://www.mdpi.com/2077-0383/13/24/7731
2. “Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review”
by John K. Appiah, Umar Hayat, Nikita Garg, Richeal Asante, Evans Donneyong, Muhammad U. Haider, Pranav Patel, Zubair Khan and Ali A. Siddiqui
J. Clin. Med. 2025, 14(17), 6119; https://doi.org/10.3390/jcm14176119
Full text available online: https://www.mdpi.com/2077-0383/14/17/6119
3. ”Recent Treatment Strategies for Acute Pancreatitis”
by Yongcook Song and Sang-Hoon Lee
J. Clin. Med. 2024, 13(4), 978; https://doi.org/10.3390/jcm13040978
Full text available online: https://www.mdpi.com/2077-0383/13/4/978
4. “What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside”
by Pojsakorn Danpanichkul, Kanokphong Suparan, Donghee Kim and Karn Wijarnpreecha
J. Clin. Med. 2024, 13(1), 278; https://doi.org/10.3390/jcm13010278
Full text available online: https://www.mdpi.com/2077-0383/13/1/278
5. “Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis”
by Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz, Manuel Barreiro-de Acosta, Míriam Mañosa, Francisco Rodríguez-Moranta, Yamile Zabana, Elena Céspedes Martínez, Ingrid Ordás and José Miranda Bautista
J. Clin. Med. 2026, 15(1), 353; https://doi.org/10.3390/jcm15010353
Full text available online: https://www.mdpi.com/2077-0383/15/1/353
6. “Physical Exercise as a Therapeutic Approach in Gastrointestinal Diseases”
by Juliana Soares Severo, Alda Cássia Alves da Silva, Brenda Lois Barros dos Santos, Thiago Sousa Reinaldo, Aureliano Machado de Oliveira, Rodrigo Soares Pereira Lima, Francisco Leonardo Torres-Leal, Armênio Aguiar dos Santos and Moisés Tolentino Bento da Silva
J. Clin. Med. 2025, 14(5), 1708; https://doi.org/10.3390/jcm14051708
Full text available online: https://www.mdpi.com/2077-0383/14/5/1708
7. “KRAS Inhibition in Pancreatic Ductal Adenocarcinoma”
by Roshini Pradeep, Nooredeen Jamal Isbeih, Freya F. Abraham, Ehsan Noori, Zachary P. Yeung and Madappa N. Kundranda
J. Clin. Med. 2026, 15(2), 873; https://doi.org/10.3390/jcm15020873
Full text available online: https://www.mdpi.com/2077-0383/15/2/873
8. “Health Literacy in Inflammatory Bowel Disease: A Systematic Review of Health Outcomes, Predictors and Barriers”
by Caterina Mercuri, Rita Nocerino, Vincenzo Bosco, Teresa Rea, Vincenza Giordano, Michele Virgolesi, Patrizia Doldo and Silvio Simeone
J. Clin. Med. 2025, 14(23), 8577; https://doi.org/10.3390/jcm14238577
Full text available online: https://www.mdpi.com/2077-0383/14/23/8577
9. “The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma”
by Faria Nusrat, Akshay Khanna, Aditi Jain, Wei Jiang, Harish Lavu, Charles J. Yeo, Wilbur Bowne and Avinoam Nevler
J. Clin. Med. 2024, 13(7), 2103; https://doi.org/10.3390/jcm13072103
Full text available online: https://www.mdpi.com/2077-0383/13/7/2103
10. “Endoscopic Management of Eosinophilic Esophagitis: A Narrative Review on Diagnosis and Treatment”
by Andrea Pasta, Francesco Calabrese, Manuele Furnari, Edoardo Vincenzo Savarino, Pierfrancesco Visaggi, Giorgia Bodini, Elena Formisano, Patrizia Zentilin, Edoardo Giovanni Giannini and Elisa Marabotto
J. Clin. Med. 2025, 14(11), 3756; https://doi.org/10.3390/jcm14113756
Full text available online: https://www.mdpi.com/2077-0383/14/11/3756
11. “VAC-Stent in the Treatment of Post-Esophagectomy Anastomotic Leaks: A New “Kid on the Block” Who Marries the Best of Old Techniques—A Review”
by Giuseppe Dell’Anna, Lorella Fanti, Jacopo Fanizza, Rukaia Barà, Alberto Barchi, Ernesto Fasulo, Ugo Elmore, Riccardo Rosati, Vito Annese and Liboria Laterza
J. Clin. Med. 2024, 13(13), 3805; https://doi.org/10.3390/jcm13133805
Full text available online: https://www.mdpi.com/2077-0383/13/13/3805
12. “Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study”
by Takao Miwa, Satoko Tajirika, Nanako Imamura, Miho Adachi, Ryo Horita, Tatsunori Hanai, Taku Fukao, Masahito Shimizu and Mayumi Yamamoto
J. Clin. Med. 2024, 13(4), 1158; https://doi.org/10.3390/jcm13041158
Full text available online: https://www.mdpi.com/2077-0383/13/4/1158
13. “A Review of the Influence of Prebiotics, Probiotics, Synbiotics, and Postbiotics on the Human Gut Microbiome and Intestinal Integrity”
by Sylwia Smolinska, Florin-Dan Popescu and Magdalena Zemelka-Wiacek
J. Clin. Med. 2025, 14(11), 3673; https://doi.org/10.3390/jcm14113673
Full text available online: https://www.mdpi.com/2077-0383/14/11/3673
14. “Unraveling the Puzzle: Health Benefits of Probiotics—A Comprehensive Review”
by Sabiha Gul and Emanuele Durante-Mangoni
J. Clin. Med. 2024, 13(5), 1436; https://doi.org/10.3390/jcm13051436
Full text available online: https://www.mdpi.com/2077-0383/13/5/1436
| Special Issues: | |
|
“Endoscopic Diagnosis and Treatments of Gastrointestinal Diseases” |
“Patient-Reported Outcomes (PROs) in Inflammatory Bowel Disease (IBD) Around the World—2nd Edition” |
 |
 |
| “Alcohol-Associated Liver Disease: Diagnosis and Treatment of Acute and Chronic Conditions” Guest Editors: Prof. Dr. Halina Cichoz-Lach and Prof. Dr. Beata Kasztelan-Szczerbińska Submission deadline: 20 November 2026 |
“New Insights into Hepato-Biliary Diseases: Translating Science into Practice” Guest Editors: Dr. Elisa Ceccherini and Dr. Antonella Cecchettini Submission deadline: 20 January 2027 |
 |
 |
6 July 2026
Meet Us at the ESC Congress 2026, 28–31 August 2026, Munich, Germany
2 July 2026
MDPI INSIGHTS: The CEO’s Letter #36 – Basel Anniversary Summit, 2025 Impact Factors & CiteScores, CSAL Partnership & ncRNA2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reflections from the MDPI 30th Anniversary Summit in Basel
On 4 June, we welcomed 30 Editors-in-Chief (EiCs) from across Europe, North America, and Asia-Pacific to A 66, MDPI’s former headquarters in Basel, for our 30th Anniversary Summit.
In the middle of the year that we celebrate 30 years since MDPI’s founding in 1996, the Summit provided an opportunity to reflect on our journey and recognize the academic community that has helped shape MDPI over the past three decades.
Designed as a small invitation-only event, the Summit brought together long-standing editorial leaders whose experience and perspectives continue to shape our journals. Throughout the day, one message emerged consistently: strong journals are built together, through partnership between publishers, editors, reviewers, and researchers.
MDPI at 30
During my opening presentation, I reflected on MDPI’s evolution from a single journal (Molecules) to a global Open Access (OA) publisher supporting more than 500 peer-reviewed journals, thousands of editors, and millions of researchers worldwide.
While our growth has been significant, our purpose remains unchanged: to help researchers communicate their work openly, efficiently, and responsibly.
I also took the opportunity to recognize that MDPI’s success has never been achieved alone. It has been built alongside our EiCs, Editorial Board Members, reviewers, authors, institutional partners, and colleagues around the world.
Agenda
The agenda combined moments for reflection, discussion, and direct engagement with our guests. The event was moderated by Damaris Critchlow (Editorial Engagement Manager, MDPI) and the program focused on dialogue rather than presentations alone, combining expert talks, panel discussions, and open forums covering:
- MDPI at 30: reflections and the road ahead
- Research integrity and editorial responsibility
- Partnerships and collaboration in publishing
- Editorial leadership and journal development
- Artificial intelligence and the future of scholarly publishing
|
|
|
|
|
|
|
|
|
|
Research Integrity and Editorial Responsibility
A key theme throughout the summit was the continued importance of research integrity and editorial independence. Tim Tait-Jamieson provided an overview of MDPI’s approach to publication ethics, emerging industry challenges, and ongoing investments in prevention, detection, and post-publication oversight. This was a key topic, as it created discussions on the evolving role of publishers, editors, and institutions in safeguarding the scientific record while maintaining transparency and trust.
Editors Panel: Building Journals and Communities
The EiC panel focused on the role of editorial leadership in developing journals and academic communities. Discussions highlighted the importance of active editorial boards, constructive peer review, community engagement, and maintaining quality as scholarly publishing continues to evolve. Thank you to our panelists: Dr. Ester Ballana (Viruses), Dr. Dilantha Fernando (Plants), and Dr. Ting Chi (Journal of Theoretical and Applied Electronic Commerce Research).
MDPI Panel: The Future of Scholarly Publishing
We also had a roundtable discussion on the future of scholarly publishing. Topics included:
- Artificial intelligence and its role in publishing workflows
- Technology and innovation in scholarly communication
- Research integrity and quality assurance
- The future of peer review
- Open Access and Open Science
- The evolving expectations of researchers, institutions, and funders
|
|
|
|
Recognizing Editorial Leadership
A highlight of the Summit was recognizing EiCs whose long-term leadership has helped strengthen both their journals and their research communities.
Through the Decade of Editorial Leadership Award and the Outstanding Editorial Impact Award, we celebrated individuals whose dedication has made a lasting contribution to scientific publishing.
|
|
|
|
As we look ahead to MDPI’s next chapter, partnerships with our editors and the wider academic community will remain central to everything we do.
Thank You
My sincere thanks to everyone who participated, and to the many colleagues whose planning and commitment made the Summit such a memorable event.
|
|
|
|
|
Impactful Research
2025 Impact Factors Released
June marked another important milestone, with the release of the 2025 Journal Citation Reports (JCR).
Learn more: https://www.mdpi.com/about/announcements/17055
This year:
- 330 MDPI journals received a Journal Impact Factor
- 254 journals increased their Impact Factor
- 29 journals received their first Journal Impact Factor
- 71% of ranked journals are now positioned in Q1 or Q2
- MDPI publications have now accumulated 25 million citations
While journal metrics should never be viewed as the sole measure of research quality, they remain an important indicator of journal visibility, community engagement, and scientific influence.
These achievements reflect the collective work of our Editors-in-Chief, Editorial Board Members, reviewers, authors, Publishing teams, and everyone involved in developing our journals.
Congratulations to every journal team that contributed to these results.
Inside MDPI
MDPI Journals Receive 2025 CiteScores
In June, Scopus published the 2025 CiteScores, providing another positive indication of the continued development of MDPI journals.
You can find more details about the 2025 CiteScore release here: Open Access, Broadly Recognized: 363 MDPI Journals Receive CiteScores for 2025
This year’s highlights include:
- 363 journals received a CiteScore
- 41 journals received a CiteScore for the first time
- 314 journals (86%) rank in Q1 or Q2
- 42 journals are now within the top 10% of their subject categories
Although no single metric defines journal quality, these results demonstrate the continued recognition and visibility of our journals across many research disciplines.
Particularly encouraging is the growing number of journals receiving their first CiteScore, reflecting years of sustained editorial development, successful indexing, and close collaboration between our Publishing teams, Indexing team, editors, and academic communities.
Thank you to everyone across MDPI whose daily work contributes to these achievements.
Coming Together for Science
Supporting Open Access in Switzerland: MDPI Renews Agreement with CSAL
I am pleased to share that MDPI has renewed its Open Access (OA) publishing agreement with the Consortium of Swiss Academic Libraries (CSAL), extending support for researchers across 24 Swiss institutions through our Institutional Open Access Program (IOAP).
As a Swiss-founded publisher, we are particularly proud to continue supporting Switzerland’s research community through long-term institutional partnerships that improve accessibility to Open Access publishing.
The renewal also coincides with the release of our 2025 Switzerland Country Report, highlighting continued national leadership in Open Science. Between 2021 and 2025, Switzerland maintained an OA publication rate of approximately 65–70%, while more than 14,000 Switzerland-affiliated papers have been published with MDPI since 2021.
“We are particularly proud to continue supporting Switzerland’s research community”
The announcement also received coverage across several leading international publishing and research news platforms, including STM, Research Information, EurekAlert!, Bytes Europe, and EdTech Innovation Hub, helping increase visibility for both the partnership and the broader discussion around OA.
My thanks to our IOAP, External Affairs, Communications, and Publishing teams, whose work continues to strengthen relationships with institutions around the world.
Closing Thoughts
Highlights from MDPI Conference ncRNA2026 in Leuven, Belgium (24–26 June)
From 24–26 June, MDPI hosted the ncRNA2026: From Molecular Mechanisms to Clinical Impact Conference in Leuven, Belgium.
The conference welcomed 125 participants from 22 countries and territories, providing an international forum for exchange across molecular biology, medicine, biotechnology, artificial intelligence, and translational research.
Bringing the Global Research Community Together
Over three days, participants exchanged ideas through:
- 4 Chair Talks
- 8 Invited Lectures
- 29 Selected Oral Presentations
- 51 Poster Presentations
Sessions covered topics including molecular biology, clinical applications, artificial intelligence, and emerging non-coding RNA research, creating a dynamic forum for scientific exchange.
|
|
|
Beyond the scientific program, the conference created opportunities for researchers, journal teams, sponsors, and academic partners to exchange ideas, build existing relationships, and create new collaborations across the global research community.
|
|
|
Our thanks to Conference Chairs Professors George Calin, Manuela Ferracin, Eleonora Leucci, and Isidore Rigoutsos, together with the invited speakers, for delivering an outstanding scientific program.
|
|
|
“By creating opportunities for researchers to exchange ideas, we continue to support the advancement of research worldwide”
Recognizing the Team
The conference also took place during an exceptional heatwave in Belgium, with temperatures reaching 38°C. Thanks to the excellent planning by the Conference team and collaboration with the venue, additional cooling measures and attendee support ensured that the event ran safely and successfully despite challenging conditions.
|
|
|
|
It is often these behind-the-scenes efforts that make the greatest difference to the participant experience. Thank you to everyone involved for your professionalism, flexibility, and commitment throughout the event.
Thank You
My sincere thanks to the Conference Chairs, invited speakers, sponsors, Editorial Office, Conference team, Marketing colleagues, volunteers, and everyone who contributed to making ncRNA2026 such a success.
As MDPI celebrates its 30th anniversary, events such as ncRNA2026 remind us that our contribution extends well beyond publishing journals. By creating opportunities for researchers to exchange ideas, establish collaborations, and build scientific communities, we continue to support the advancement of research worldwide.
Thank you for your continued dedication throughout another busy month, and I wish you all an enjoyable July!
Chief Executive Officer
MDPI AG
1 July 2026
Journal of Clinical Medicine | Highly Cited Papers and Hot Topic Special Issues on Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disease with an unstable clinical course. Early diagnosis, timely intervention, and treatment management, as well as the understanding of the mechanisms and managing associated complications, are key areas of research in clinical practice. The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is ranked 67/336 (Q1) in the “Medicine, General and Internal” category. We invite you to review the selected highly cited papers and several hot topic Special Issues focused on Alzheimer’s disease. We hope these papers can inspire novel insights and offer valuable references for your research.
Furthermore, to discover more publications on the topic of Alzheimer’s disease, please click here. We welcome you to participate in a free online conference, “The 4th International Online Conference on Clinical Medicine” (IOCCM 2026), which includes the “Clinical Neurology” Section. Abstract submissions for this conference are open until 7 August 2026.
For further details, please visit https://www.mdpi.com/journal/jcm/events.
1. “Trace Elements in Alzheimer’s Disease and Dementia: The Current State of Knowledge”
by Magdalena Tyczyńska, Marta Gędek, Adam Brachet, Wojciech Stręk, Jolanta Flieger, Grzegorz Teresiński and Jacek Baj
J. Clin. Med. 2024, 13(8), 2381; https://doi.org/10.3390/jcm13082381
Full text available online: https://www.mdpi.com/2077-0383/13/8/2381
2. “Novel Therapeutic Strategies in Alzheimer’s Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond”
by Giacomo Tondo, Fabiola De Marchi, Francesca Bonardi, Federico Menegon, Gaia Verrini, Davide Aprile, Matteo Anselmi, Letizia Mazzini and Cristoforo Comi
J. Clin. Med. 2024, 13(11), 3098; https://doi.org/10.3390/jcm13113098
Full text available online: https://www.mdpi.com/2077-0383/13/11/3098
3. “Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer’s Disease”
by Jelena Rajič Bumber, Valentino Rački, Silvestar Mežnarić, Gordana Pelčić and Jasenka Mršić-Pelčić
J. Clin. Med. 2025, 14(17), 6047; https://doi.org/10.3390/jcm14176047
Full text available online: https://www.mdpi.com/2077-0383/14/17/6047
4. “Mild Cognitive Impairment Progression and Alzheimer’s Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months”
by Nevra Öksüz, Reza Ghouri, Bahar Taşdelen, Derya Uludüz and Aynur Özge
J. Clin. Med. 2024, 13(2), 518; https://doi.org/10.3390/jcm13020518
Full text available online: https://www.mdpi.com/2077-0383/13/2/518
5. “Metabolic and Immune System Dysregulation: Unraveling the Connections between Alzheimer’s Disease, Diabetes, Inflammatory Bowel Diseases, and Rheumatoid Arthritis”
by Julia Doroszkiewicz, Jan Mroczko, Izabela Winkel and Barbara Mroczko
J. Clin. Med. 2024, 13(17), 5057; https://doi.org/10.3390/jcm13175057
Full text available online: https://www.mdpi.com/2077-0383/13/17/5057
6. “Erythrocyte Load in Cerebrospinal Fluid Linked with Hippocampal Atrophy in Alzheimer’s Disease”
by Rafail Christodoulou, Georgios Vamvouras, Laura Lorentzen and Evros Vassiliou
J. Clin. Med. 2025, 14(13), 4670; https://doi.org/10.3390/jcm14134670
Full text available online: https://www.mdpi.com/2077-0383/14/13/4670
7. “Artificial Intelligence in Alzheimer’s Disease Diagnosis and Prognosis Using PET-MRI: A Narrative Review of High-Impact Literature Post-Tauvid Approval”
by Rafail C. Christodoulou, Amanda Woodward, Rafael Pitsillos, Reina Ibrahim and Michalis F. Georgiou
J. Clin. Med. 2025, 14(16), 5913; https://doi.org/10.3390/jcm14165913
Full text available online: https://www.mdpi.com/2077-0383/14/16/5913
8. “Efficacy of Transcranial Direct Current Stimulation and Photobiomodulation in Improving Cognitive Abilities for Alzheimer’s Disease: A Systematic Review”
by Monica Cornea, Bogdan Ioan Vintilă, Mihaela Bucuța, Laura Ștef, Claudia Elena Anghel, Andreea Maria Grama, Andrei Lomnasan, Andreea Angela Stetiu, Adrian Boicean and Mihai Sava et al.
J. Clin. Med. 2025, 14(5), 1766; https://doi.org/10.3390/jcm14051766
Full text available online: https://www.mdpi.com/2077-0383/14/5/1766
9. “Biomarker-Based Precision Therapy for Alzheimer’s Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine”
by Anastasia Bougea and Philippos Gourzis
J. Clin. Med. 2024, 13(16), 4661; https://doi.org/10.3390/jcm13164661
Full text available online: https://www.mdpi.com/2077-0383/13/16/4661
10. “Charting Alzheimer’s Disease and Dementia: Epidemiological Insights, Risk Factors and Prevention Pathways”
by Israel Contador, Bárbara Buch-Vicente, Teodoro del Ser, Sara Llamas-Velasco, Alberto Villarejo-Galende, Julián Benito-León and Félix Bermejo-Pareja
J. Clin. Med. 2024, 13(14), 4100; https://doi.org/10.3390/jcm13144100
Full text available online: https://www.mdpi.com/2077-0383/13/14/4100
11. “Behavioral Disorders of Spatial Cognition in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease: Preliminary Findings from the BDSC-MCI Project”
by Davide Maria Cammisuli, Valeria Isella, Federico Verde, Vincenzo Silani, Nicola Ticozzi, Simone Pomati, Virginia Bellocchio, Valentina Granese, Benedetta Vignati, Gloria Marchesi et al.
J. Clin. Med. 2024, 13(4), 1178; https://doi.org/10.3390/jcm13041178
Full text available online: https://www.mdpi.com/2077-0383/13/4/1178
|
Special Issues: |
|
|
“Cognitive Impairment, Dementia and Depression in Older Adults” |
“Innovative Therapies for Neurological Disorders” |
|
|
|
|
“Clinical Interventions for Cognitive Impairment and Neurological Disorders” |
“Towards an Improved Understanding of Alzheimer's and Related Dementias: Interdisciplinary and Clinical Progress” |
|
|
|
24 June 2026
Journal of Clinical Medicine Receives an Updated Impact Factor of 3.3
24 June 2026
MDPI Open Science Insights: Academic Publishing Workshop at the Fundació Assistencial de Mútua de Terrassa, 3 July 2026
MDPI is excited to collaborate with the Fundació Assistencial de Mútua de Terrassa to host an Academic Publishing Workshop in the Department of Mental Health aimed at empowering researchers with the knowledge and tools needed for successful academic publishing. This workshop will cover key aspects of MDPI’s open access publishing model, including journal selection, editorial workflow, and publication ethics. Participants will receive practical tips on improving their scientific writing and addressing reviewer comments, guided by experienced editors.
Date: 3 July 2026
Time: 12:00–13:30
Venue: Fundació Assistencial de Mútua de Terrassa
Schedule:
|
Program and Content |
Time |
|
Introduction to MDPI & Open Access |
12:00–12:15 |
|
Introduction to the journals and their mental health-related Sections of Healthcare, JCM & Women |
12:15-12:30 |
|
Editorial Process & Peer Review |
12:30–12:50 |
|
Research Integrity & IA in Academic Publishing |
12:50–13:05 |
|
Q&A Session |
13:05–13:30 |
Chair:
 |
Dr. Jose Antonio Monreal |
Speakers:
 |
Mr. Iñigo Aristizabal is a biochemist with extensive expertise in the academic publishing industry. He joined the MDPI office in Barcelona as an Assistant Editor in November 2017 and has since served as a Section Managing Editor and, more recently, as a Journal Relations Specialist. He primarily supports MDPI’s journals Genes, Cardiogenetics, DNA, and J (Multidisciplinary Scientific Journal) by coordinating scholarly meetings and managing booth attendance at both virtual and in-person conferences. |
 |
Ms. Caral Zhou holds a master’s degree from the University of Barcelona, Spain. She began her career at MDPI in 2023, working with the International Journal of Molecular Sciences (IJMS) and the Journal of Functional Morphology and Kinesiology (JFMK). In 2024, she advanced to the position of Section Managing Editor, and in 2025, she was appointed Deputy Managing Editor for JFMK, where she continues to contribute the journal’s development and collaboration initiatives. |
22 June 2026
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026
22 June 2026
MDPI’s Journal Cluster of Hematology Webinar | Multiple Myeloma: Updates from EHA Conference, 24 June 2026
As multiple myeloma management continues to evolve, it brings new challenges and opportunities in daily clinical practice. This webinar will provide updates from EHA 2026, giving you an opportunity to review recent developments and exchange perspectives on current approaches to patient care in smoldering myeloma in frontline and relapsed/refractory settings.
Date: 24 June 2026 at 6:00 p.m. CEST | 12:00 p.m. EDT
Webinar ID: 879 4003 9407
Register now for free!
Program:
| Speaker/Presentation | Time in CEST | Time in EDT |
| Prof. Dr. Claudio Cerchione Chair Introduction |
6:00–6:10 p.m. | 12:00–12:10 p.m. |
| Prof. Dr. Claudio Cerchione How I Treat Multiple Myeloma in Europe |
6:10–6:30 p.m. | 12:10–12:30 p.m. |
| Dr. Mamta Krishnan Garg Early Diagnosis of Myeloma and Frontline Treatment |
6:30–6:50 p.m. | 12:30–12:50 p.m. |
| Dr. Montefusco Vittorio Relapsed/Refractory Multiple Myeloma: Key Updates from EHA 2026 |
6:50–7:10 p.m. | 12:50–1:10 p.m. |
| Dr. Vanessa Desantis Biology of Multiple Myeloma and New Tools with Potential Impact on Daily Practice: Main Key Updates from EHA 2026 |
7:10–7:30 p.m. | 1:10–1:30 p.m. |
| Q&A Session | 7:30–7:45 p.m. | 1:30–1:45 p.m. |
| Prof. Dr. Claudio Cerchione Closing of Webinar |
7:45–7:50 p.m. | 1:45–1:50 p.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Prof. Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy;
- Dr. Mamta Krishnan Garg, British Society Haematology Task Force Representative, London, UK;
- Dr. Montefusco Vittorio, Division of Hematology, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e Carlo, Milano, Italy;
- Dr. Vanessa Desantis, Pharmacology Section, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro Medical School, Bari, Italy.
17 June 2026
Journal of Clinical Medicine | Collaboration Established with the Japanese Society of Renal Transplantation and Vascular Surgery (RTVS)
Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has established a society collaboration with the Japanese Society for Renal Transplantation and Vascular Surgery (RTVS). As part of this, all RTVS members will receive a discount on applicable article processing charges (APCs) when submitting original articles to JCM. We appreciate all RTVS members keeping up with our journal and sharing this member-specific APC discount policy with their peers.
RTVS is an academic society whose members are primarily urologists. Founded in 1988, the society has just over 500 members. Its mission is to conduct research on kidney transplantation and vascular surgery, thereby contributing to the advancement of medical care. The society also addresses vascular management in urologic malignancies, vascular access procedures in dialysis medicine, renal replacement therapy, vascular surgery in oncology, and pharmacological treatment. Its principal activities include holding an annual scientific meeting, organizing lectures and research seminars, conducting educational courses and collecting research materials, among other activities.
For more information on our society collaborations, please visit the journal’s website.
